BE THE PARTNER INC - US 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 7.447.875 256.810 1
2018 0 7.437.128 440.275 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
INNOVATION ACTA2
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA1
BE THE PARTNER1
FONDAZIONE POLIAMBULANZA1
ICON CLINICAL RESEARCH LIMITED1
INTERNATIONAL OSTEOPOROSIS FOUNDATION1
KINETO TECH REHAB1
NORDIC BIOSCIENCE1
OULUN YLIOPISTO1
OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST1
PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG PRIVATSTIFTUNG1
PLURI BIOTECH1
PLURISTEM1
QUEENSLAND UNIVERSITY OF TECHNOLOGY QLD QUT1
REGION SYDDANMARK1
STICHTING REUMANEDERLAND1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1

Constancy:

Total number of partners: 20
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 20
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01PROTO - Advanced PeRsOnalized Therapies for Osteoarthritis – TACKLING INFLAMMATION TO IMPROVE PATIENT OUTCOMES PROTOparticipant7.447.87510
2018-01-01Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial HIPGENparticipant7.437.12812